Louis P. Garrison
Directeur/Bestuurslid bij International Society for Pharmacoeconomics & Outcomes Rsch
Profiel
Louis P.
Garrison is currently the Director at the International Society for Pharmacoeconomics & Outcomes Research.
He holds a doctorate degree from Stanford University and an undergraduate degree from Indiana University.
Actieve functies van Louis P. Garrison
| Bedrijven | Functie | Begin |
|---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
 International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Directeur/Bestuurslid | - |
Opleiding van Louis P. Garrison
| Indiana University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |
